Search | SocialyTime

Rahul Rangwa added blog Other
2026-05-06 08:18:45 -

API Contract Manufacturing Market Booms with Pharmaceutical Outsourcing Trends
"API Contract Manufacturing Market Summary: According to the latest report published by Data Bridge Market Research, the API Contract Manufacturing Market CAGR Value The Global API Contract Manufacturing Market size was valued at USD 8.1 billion in 2024 and is expected to reach USD 12.57 billion by 2032, at a CAGR of 5.87% during the forecast...

0 Comments 0 Shares 349 Views 0 Reviews

Please log in to like, share and comment!
Subodh Adke added blog Networking
2026-04-29 12:02:59 -

Global (S)-Omeprazole Magnesium Dihydrate Market Outlook 2026-2034: Esomeprazole API Growth, GERD Treatment Demand & Pharmaceutical Expansion Trends
Global (S)-Omeprazole magnesium dihydrate (CAS 217087-10-0) market was valued at USD 680.4 million in 2025 and is projected to reach USD 1.21 billion by 2034, exhibiting a remarkable CAGR of 6.7% during the forecast period. (S)-Omeprazole magnesium dihydrate, also known as esomeprazole magnesium dihydrate, the pure S-enantiomer of omeprazole in its magnesium salt dihydrate form, has...

0 Comments 0 Shares 384 Views 0 Reviews

Please log in to like, share and comment!
Subhayan Mayra added blog Other
2026-04-15 11:50:13 -

Brigatinib API Market Growing at 8.1% CAGR Through 2034 Globally
According to a new report from Intel Market Research, the global Brigatinib API market was valued at USD 42.5 million in 2025 and is projected to reach USD 89.7 million by 2034, growing at a robust CAGR of 8.1% during the forecast period (2026–2034). This growth is propelled by the increasing global incidence of non-small cell lung cancer, particularly ALK-positive cases among...

0 Comments 0 Shares 1K Views 0 Reviews

Please log in to like, share and comment!
Subhayan Mayra added blog Other
2026-06-05 12:36:52 -

Global Cefalexin API Market to Reach USD 871 Million by 2034
According to a new report from Intel Market Research, the global Cefalexin API market was valued at USD 571 million in 2024 and is projected to reach USD 871 million by 2034, growing at a robust CAGR of 6.4% during the forecast period (2025–2034). This growth is propelled by the increasing prevalence of bacterial infections, rising demand for generic antibiotics, and expanding...

0 Comments 0 Shares 128 Views 0 Reviews

Please log in to like, share and comment!